Nanoform Finland Oyj (STO:NANOFS)
12.26
+0.14 (1.16%)
At close: Oct 31, 2025
Nanoform Finland Oyj Revenue
Nanoform Finland Oyj had revenue of 667.00K EUR in the quarter ending June 30, 2025, with 2.46% growth. This brings the company's revenue in the last twelve months to 3.95M, up 72.18% year-over-year. In the year 2024, Nanoform Finland Oyj had annual revenue of 3.66M with 42.70% growth.
Revenue (ttm)
3.95M EUR
Revenue Growth
+72.18%
P/S Ratio
24.11
Revenue / Employee
21.84K EUR
Employees
181
Market Cap
1.06B SEK
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.66M | 1.10M | 42.70% |
| Dec 31, 2023 | 2.57M | -920.89K | -26.41% |
| Dec 31, 2022 | 3.49M | 1.53M | 78.42% |
| Dec 31, 2021 | 1.95M | 1.25M | 178.38% |
| Dec 31, 2020 | 702.12K | 421.69K | 150.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.22B |
| Elekta AB | 17.84B |
| Asker Healthcare Group AB | 15.88B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |